mounjaro tirzepatide injection eli lilly (tirzepatide) for the Treatment of Type 2 Diabetes, USA Lilly Seeks Mounjaro Approval for

Caution is advised in individuals with a history of pancreatitis

doi: 10.3389/fphar.2025.1615681 Received 23 May 2025 Accepted 14 July 2025 Published 24 July 2025 Volume 16 - 2025 Edited by Eoin Daniel OSullivan, Royal Brisbane and Womens Hospital, Australia Reviewed by Prerna Kumar, Tulane University, United States David Baird, University of Edinburgh, United Kingdom Sumaya Akter, Noakhali Science and Technology University, Bangladesh Saswat Kumar Mohanty, Brown University, United States Updates Copyright 2025 Zhang, Ni, Lin, Wang, He, Yuan, Han and Zuo

The KRASG12C inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-Mutant cancers in mouse models and patients

Kuchay MS, Krishan S, Mishra SK, Farooqui KJ, Singh MK, Wasir JS, et al